| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14656566.2010.511614 |
| P953 | full work available at URL | http://www.informapharmascience.com/doi/abs/10.1517/14656566.2010.511614 |
| http://www.tandfonline.com/doi/pdf/10.1517/14656566.2010.511614 | ||
| P698 | PubMed publication ID | 20955116 |
| P2093 | author name string | Solen Pichereau | |
| Warren E. Rose | |||
| P2860 | cites work | Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. | Q46560630 |
| Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms | Q46620675 | ||
| The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam | Q46634329 | ||
| In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). | Q46654694 | ||
| Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance | Q46731353 | ||
| Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital | Q46735162 | ||
| Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? | Q46759948 | ||
| Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers | Q46859108 | ||
| Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619. | Q46985670 | ||
| Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group | Q48029530 | ||
| Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. | Q51643088 | ||
| Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection | Q54262512 | ||
| Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 | ||
| Treatment of severe staphylococcal infections with a rifampicin-minocycline association | Q70590496 | ||
| Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment | Q73510393 | ||
| Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus | Q73850011 | ||
| Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus | Q79453357 | ||
| Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005) | Q79616255 | ||
| Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus | Q80363319 | ||
| The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA | Q80531337 | ||
| Daptomycin | Q80608154 | ||
| A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin | Q83104365 | ||
| Pediatric Infectious Disease Journal | Q15756717 | ||
| The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria | Q24519053 | ||
| Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus | Q24556635 | ||
| Tigecycline: first of a new class of antimicrobial agents | Q28253736 | ||
| Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis | Q28333659 | ||
| Chemical biology of tetracycline antibioticsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process. | Q29030024 | ||
| Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and update | Q30228586 | ||
| A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections | Q30229201 | ||
| Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. | Q30367325 | ||
| Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs | Q33245188 | ||
| Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). | Q33702686 | ||
| Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus | Q33754412 | ||
| Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections | Q33836490 | ||
| Waves of resistance: Staphylococcus aureus in the antibiotic era. | Q33854398 | ||
| Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers | Q33857651 | ||
| In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates | Q33876626 | ||
| In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria | Q33979123 | ||
| The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections | Q34330270 | ||
| Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections | Q34352287 | ||
| The importance of bactericidal drugs: future directions in infectious disease. | Q34360508 | ||
| Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus | Q34402839 | ||
| Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y | Q34426508 | ||
| Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community | Q34438505 | ||
| Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus | Q34481625 | ||
| Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target | Q34510488 | ||
| Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus | Q34558111 | ||
| Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients | Q34560162 | ||
| Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection | Q34600791 | ||
| Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. | Q34603556 | ||
| Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae | Q34624359 | ||
| A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. | Q34773796 | ||
| Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study | Q34900607 | ||
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 | ||
| Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci | Q34928138 | ||
| Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release | Q34937048 | ||
| Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001 | Q34939045 | ||
| Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic | Q34941521 | ||
| Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia | Q34973729 | ||
| Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii | Q34996383 | ||
| Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children | Q35160650 | ||
| Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus | Q35166213 | ||
| Daptomycin | Q35637066 | ||
| Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections | Q35638010 | ||
| Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin | Q35758808 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak | Q35778624 | ||
| Methicillin-resistant Staphylococcus aureus in community-acquired skin infections | Q36009334 | ||
| Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature | Q36103613 | ||
| Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat | Q36108084 | ||
| Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia | Q36313264 | ||
| Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy | Q36328976 | ||
| Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. | Q36409465 | ||
| Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding | Q36422686 | ||
| Community-associated meticillin-resistant Staphylococcus aureus | Q36438720 | ||
| An antidote for Staphylococcus aureus pneumonia? | Q36502876 | ||
| First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States | Q36702968 | ||
| Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus | Q36744836 | ||
| Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: management principles and selection of antibiotic therapy | Q36790244 | ||
| New antimicrobial agents as therapy for resistant gram-positive cocci | Q36953330 | ||
| Daptomycin: a review 4 years after first approval | Q36972980 | ||
| Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity | Q37030780 | ||
| Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection | Q37058032 | ||
| Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus | Q37153787 | ||
| Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies | Q37153972 | ||
| Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains | Q37156698 | ||
| Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. | Q37392917 | ||
| Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus | Q37449007 | ||
| Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe | Q37718313 | ||
| Ceftaroline for complicated skin and skin-structure infections. | Q37733561 | ||
| In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus | Q38899451 | ||
| High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections | Q39708441 | ||
| Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci | Q40133451 | ||
| Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers | Q40242696 | ||
| Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. | Q40602489 | ||
| In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations | Q41269599 | ||
| Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections | Q41762607 | ||
| Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis | Q41847174 | ||
| A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline | Q42028209 | ||
| Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States | Q42126345 | ||
| In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model | Q42627381 | ||
| Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102). | Q43160505 | ||
| Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection | Q43295880 | ||
| Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid | Q43740901 | ||
| Efficacy of trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus: a report from Tunisia | Q43840989 | ||
| Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children | Q44104837 | ||
| Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro | Q44616846 | ||
| Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia | Q44647040 | ||
| Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection | Q44686515 | ||
| Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin | Q44721295 | ||
| Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. | Q45119835 | ||
| Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections | Q45157534 | ||
| Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? | Q45228183 | ||
| Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. | Q45944031 | ||
| Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. | Q46047025 | ||
| Clinical decisions. Management of skin and soft-tissue infection--polling results. | Q46325191 | ||
| Methicillin-resistant Staphylococcus aureus disease in three communities | Q46426018 | ||
| Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles | Q46426023 | ||
| Three-year surveillance of community-acquired Staphylococcus aureus infections in children | Q46503394 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 3009-3025 | |
| P577 | publication date | 2010-10-19 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Invasive community-associated MRSA infections: epidemiology and antimicrobial management | |
| P478 | volume | 11 |
| Q35582478 | A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia |
| Q36712172 | A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection |
| Q30353780 | Community-acquired methicillin-resistant Staphylococcus aureus: the new face of an old foe? |
| Q35941253 | Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model |
| Q38911563 | Experiences of nursing staff caring for patients with methicillin-resistant Staphylococcus aureus |
| Q34666739 | Incidence and risk factors of the secondary skin infections in patients with radiodermatitis |
| Q38075466 | Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review |
| Q36222200 | Pilot Study with regard to the Wound Healing Activity of Protein from Calotropis procera (Ait.) R. Br. |
| Q91650104 | Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus |
| Q35599638 | Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity. |
| Q39165124 | Update on management of skin and soft tissue infections in the emergency department |
Search more.